
SKB264 led to durable responses and a manageable safety profile in patients with gastric or gastroesophageal junction cancers, an expert said.

SKB264 led to durable responses and a manageable safety profile in patients with gastric or gastroesophageal junction cancers, an expert said.

I've found that nutrition and healthy foods play an important role during cancer.

There is no difference in recovery, complication or cost between the two most common surgical approaches for esophageal cancer.

CAN-2409 has been associated with improved survival among patients with non-metastatic, borderline resectable pancreatic ductal adenocarcinoma.

The novel treatment, zanidatamab, has been submitted to the FDA via a Biologics License Application for patients with HER2-positive biliary tract cancer.

After five years of being cancer-free, my oncologist said I'm graduated and can live my life freely.

Enhertu has been approved by the FDA for certain patients with unresectable or metastatic HER2-positive solid tumors.

When I was my husband's caregiver, I tried to make things comfortable, but I'm not sure if the drugs and bedpans could ever make it right.

The GI cancer space has “made huge strides” in recent years, which opened more options for patients with a type of esophageal cancer, an expert said.

Here are four signs of your doctor not listening and four things I do when they don't listen to me.

Certain oral chemotherapies may cause hand-foot syndrome, but reducing the dose of the drug allows it to heal, an expert told CURE®.

Moderate multivitamin use was associated with a decreased risk of death in patients with colorectal cancer, though more research is needed, an expert said.

The Food and Drug Administration approved Tevimbra for pretreated metastatic or unresectable esophageal squamous cell carcinoma.

Although many hate drinking the prep for colonoscopies, I view it as a privilege.

From TikTok singer Cat Janice dying of cancer to Taylor Swift giving a 9-year-old with brain cancer the “22” hat during a recent concert, here is what’s happening in the oncology space this week.

The Food and Drug Administration has accepted a Biologics License Application for Tevimbra with chemotherapy for the first-line treatment of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma.

After I was diagnosed with colon cancer, I learned to take care of myself more and be more outspoken than ever before.

A patient in a phase 2 trial has received the first dose of a novel combination of botensilimab and balstilimab plus agenT-979, an allogeneic cell therapy.

Spending a fourth of my life as a cancer survivor, I’ve learned a few lessons along the way.

I wondered how much I could contribute to cholangiocarcinoma awareness, but determined that if I help just one person, then that's a success.

The Food and Drug Administration has approved Onivyde with oxaliplatin, fluorouracil and leucovorin, for the first-line treatment of patients with metastatic pancreatic adenocarcinoma, the agency has announced.

Country singer Toby Keith died Monday after receiving a stomach cancer diagnosis in 2022.

One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.

Slower infusion rates of antiemetic drugs may help manage nausea and vomiting in patients with gastric or gastroesophageal junction cancers.

A vaccine for pancreatic and colorectal cancers is showing promise, but potential availability of the drug is likely several years away, an expert said.